MedPath

Nebivolol

Generic Name
Nebivolol
Brand Names
Bystolic
Drug Type
Small Molecule
Chemical Formula
C22H25F2NO4
CAS Number
118457-14-0
Unique Ingredient Identifier
030Y90569U

Overview

Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than atenolol, propranolol, or pindolol. Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics. Nebivolol was granted FDA approval on 17 December 2007.

Background

Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than atenolol, propranolol, or pindolol. Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics. Nebivolol was granted FDA approval on 17 December 2007.

Indication

Nebivolol is indicated to treat hypertension.

Associated Conditions

  • Hypertension

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2008/10/20
Phase 4
Completed
2008/10/10
Phase 4
Completed
Forest Laboratories
2008/08/29
Phase 4
Completed
Forest Laboratories
2008/08/14
Phase 4
Completed
Forest Laboratories
2008/05/23
Phase 3
UNKNOWN
Fondazione IRCCS Policlinico San Matteo di Pavia
2008/05/07
Phase 4
Completed
Forest Laboratories
2008/05/07
Phase 4
Completed
Forest Laboratories
2008/04/01
Phase 3
Completed
Forest Laboratories
2007/10/22
Phase 3
Terminated
Forest Laboratories
2007/08/17
Phase 4
Completed
Centro Cardiologico Monzino

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Solco Healthcare US, LLC
43547-526
ORAL
10 mg in 1 1
2/14/2022
Golden State Medical Supply, Inc.
51407-483
ORAL
2.5 mg in 1 1
8/24/2023
Macleods Pharmaceuticals Limited
33342-457
ORAL
2.5 mg in 1 1
4/8/2025
Modavar Pharmaceuticals LLC
72241-032
ORAL
2.5 mg in 1 1
11/9/2023
Golden State Medical Supply, Inc.
51407-484
ORAL
5 mg in 1 1
8/24/2023
A-S Medication Solutions
50090-5761
ORAL
10 mg in 1 1
4/13/2022
Physicians Total Care, Inc.
54868-5944
ORAL
5 mg in 1 1
1/3/2012
Physicians Total Care, Inc.
54868-6018
ORAL
10 mg in 1 1
1/3/2012
Unichem Pharmaceuticals (USA), Inc.
29300-377
ORAL
10 mg in 1 1
7/11/2023
Ascend Laboratories, LLC
67877-391
ORAL
10 mg in 1 1
7/13/2023

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath